LOWELL, Mass., Feb. 05, 2018 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Mike Noyes as Vice President of Operations. Mike will report directly to the CEO, Robert Spignesi.
Mr. Noyes brings over 25 years of executive Operations experience with leading medical device companies. Most recently, he held the position of Vice President of Operations at Smith Medical, where he successfully developed a new manufacturing footprint and network optimization strategy and managed all North American manufacturing facilities with over 4,000 employees. Previously, Mr. Noyes held multiple Operations positions at Smith Group including VP, Operations North America and Regional Director, Northeast Operations. Mr. Noyes’ prior experience includes positions at Medtronic Corporation, Angiolink, Galileo Corporation, Tyco Healthcare, and Cordis.
“I am delighted to have an executive of Mike’s caliber and experience to join our executive team,” said CEO Robert Spignesi. “His track record of developing operations strategies in addition to optimizing and scaling manufacturing processes across global site networks will be instrumental to our continued growth and success.”
“I am excited to join the team at Rapid Micro Biosystems as VP of Operations and take on this assignment as the company develops to become the leader in automated, rapid microbiology detection method,” said Mr. Noyes.
Mike holds a M.S. degree in Mechanical Engineering from Columbia University, an MBA from Nova Southeastern University and a B.S. degree in Electrical Engineering from Northeastern University.
About Rapid Micro Biosystems
Rapid Micro Biosystems creates innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products. The company’s Growth Direct™—the first and only growth-based system to automate compendial testing—detects contamination more quickly, delivering compelling economic benefits to manufacturers while improving their quality control (QC) process.
Contact:
Eugenia Kendrick
Rapid Micro Biosystems
[email protected]


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Anta Sports Expands Global Footprint With Strategic Puma Stake
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



